Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Sep 30;8(9):e12944.
doi: 10.2196/12944.

Development of Ovarian Tissue Autograft to Restore Ovarian Function: Protocol for a French Multicenter Cohort Study

Jean-Baptiste Pretalli #  1   2 , Sophie Frontczak Franck #  2 , Lionel Pazart  1   3 , Christophe Roux  1   2   4 , Clotilde Amiot  1   2   4 ; DATOR Group
Collaborators, Affiliations

Development of Ovarian Tissue Autograft to Restore Ovarian Function: Protocol for a French Multicenter Cohort Study

Jean-Baptiste Pretalli et al. JMIR Res Protoc. .

Abstract

Background: Sterility is a major late effect of radiotherapy and chemotherapy treatments. Iatrogenic sterility is often permanent and greatly impacts long-term quality of life. Ovarian tissue cryopreservation (OTC) performed before gonadotoxic treatments with subsequent autograft is a method of fertility preservation available for girls and women. Its application in prepubertal girls is of particular value as it is the only possible approach in this patient group. In addition, it does not require a delay in cancer therapy and no ovarian stimulation is needed.

Objective: The primary aim of this protocol is to help increase the implementation of ovarian tissue autografting in France. Knowledge is still lacking regarding the efficacy of ovarian transplantation in restoring ovarian function and regarding the safety of this procedure, especially the risk of cancer cell reseeding in certain types of cancer. A secondary aim of this study is to generate data to improve our understanding of these two essential aspects.

Methods: The DATOR (Development of Ovarian Tissue Autograft in Order to Restore Ovarian Function) study is ongoing in 17 university hospitals. The DATOR protocol includes the autograft of ovarian cortex fragments. Candidates are identified from an observational prospective cohort (called the Prospective Cohort of Patients Candidates for Ovarian Tissue Autograft [PERIDATOR]) of patients who have undergone OTC. Enrollment in the study is initiated at the patient's request and must be validated by the center's multidisciplinary team and by the study steering committee. The DATOR study begins with a total medical checkup. Ovarian tissue qualification and residual disease detection, if required, are performed.

Results: The study is ongoing. Currently, 38 patients have provided informed consent and have been entered into the DATOR study. Graft has been performed for 34 of these patients. An interim analysis was conducted on the first 25 patients for whom the period of at least 1 year posttransplantation was achieved. Out of these 25 patients, 11 women succeeded in becoming pregnant (pregnancy rate=44% [11/25]; delivery rate=40% [10/25]). Among these, 6 women conceived twice, and 1 pregnancy led to a miscarriage.

Conclusions: Our preliminary analysis appears to be coherent with the accumulating body of evidence indicating the potential utility of ovarian tissue autograft for patients with premature ovarian failure. All these elements justify the pursuit of our study.

Trial registration: ClinicalTrials.gov NCT02846064; https://clinicaltrials.gov/ct2/show/NCT02846064.

International registered report identifier (irrid): DERR1-10.2196/12944.

Keywords: cohort study; cryopreservation; fertility preservation; live birth rate; ovarian tissue; pregnancy rate.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: None declared.

Figures

None
Study flowchart.
None
Flowchart of the preliminary analysis. DATOR: Development of Ovarian Tissue Autograft in Order to Restore Ovarian Function.
None
Box plots of monthly follicle-stimulating hormone levels during the year after autograft for the no pregnancy (blue) and the pregnancy group (red). For each group, the curves represent the monthly follicle-stimulating hormone means for the no pregnancy (blue curve) and for the pregnancy group (red curve), respectively. FSH: follicle-stimulating hormone.
See this image and copyright information in PMC

References

    1. Croucher C, Whelan JS, Møller H, Davies EA. Trends in the incidence and survival of cancer in teenagers and young adults: regional analysis for South East England 1960-2002. Clin Oncol (R Coll Radiol) 2009 Jun;21(5):417–24. doi: 10.1016/j.clon.2009.02.006. - DOI - PubMed
    1. Aben KK, van Gaal C, van Gils NA, van der Graaf WT, Zielhuis GA. Cancer in adolescents and young adults (15-29 years): a population-based study in the Netherlands 1989-2009. Acta Oncol. 2012 Sep;51(7):922–33. doi: 10.3109/0284186X.2012.705891. - DOI - PubMed
    1. Cancer Research UK. [2018-10-24]. Young People's Cancers Statistics http://www.cancerresearchuk.org/health-professional/cancer-statistics/te....
    1. Desandes E, Lacour B, Sommelet D, Danzon A, Delafosse P, Grosclaude P, Mace-Lesech J, Maarouf N, Marr A, Raverdy-Bourdon N, Tretarre B, Velten M, Brugieres L. Cancer survival among adolescents in France. Eur J Cancer. 2006 Feb;42(3):403–9. doi: 10.1016/j.ejca.2005.07.035. - DOI - PubMed
    1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ. Cancer statistics, 2008. CA Cancer J Clin. 2008;58(2):71–96. doi: 10.3322/CA.2007.0010. doi: 10.3322/CA.2007.0010. - DOI - DOI - PubMed

Associated data